Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4874486
Max Phase: Preclinical
Molecular Formula: C17H20N2O4
Molecular Weight: 316.36
Molecule Type: Unknown
Associated Items:
ID: ALA4874486
Max Phase: Preclinical
Molecular Formula: C17H20N2O4
Molecular Weight: 316.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCONC(=O)c1cccc2ccccc12)NO
Standard InChI: InChI=1S/C17H20N2O4/c20-16(18-22)11-2-1-5-12-23-19-17(21)15-10-6-8-13-7-3-4-9-14(13)15/h3-4,6-10,22H,1-2,5,11-12H2,(H,18,20)(H,19,21)
Standard InChI Key: PNBXRTHKXVSYBU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.36 | Molecular Weight (Monoisotopic): 316.1423 | AlogP: 2.57 | #Rotatable Bonds: 8 |
Polar Surface Area: 87.66 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.91 | CX Basic pKa: | CX LogP: 2.27 | CX LogD: 2.26 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.40 | Np Likeness Score: -0.58 |
1. Alves Avelar LA, Schrenk C, Sönnichsen M, Hamacher A, Hansen FK, Schliehe-Diecks J, Borkhardt A, Bhatia S, Kassack MU, Kurz T.. (2021) Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors., 211 [PMID:33360560] [10.1016/j.ejmech.2020.113095] |
Source(1):